In this issue:
Treatment of primary disease
Chemoradiation in unresectable disease
Screening
Estimating CRC rescreening intervals
BMI and colon cancer recurrence
Metastatic disease
R1 and R0 survival rates in CLM
DFS after hepatic resection for CLM
Adjuvant chemo in liver-metastatic CRC
Chemo for primary cancer in situ?
Predictive factors in metastatic disease
KRAS testing before cetuximab?
Pharmacogenetic profiling in CRC
Circulating tumour cells in mCRC
Please login below to download this issue (PDF)